Canna Law Blog has an interesting post comparing the cannabis and psilocybin movements.

  • Like cannabis, it describes psilocybin reform as advancing along a “two-track” model: local ordinances on one hand and pharmaceuticals.
  • The local ordinances, “Do not contemplate a commercial model and it seems unlikely that they will be lucrative.”
  • However, “The FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place.”
  • Nearly 100 U.S. cities are exploring psilocybin decriminalization.